Share Name Share Symbol Market Type Share ISIN Share Description
Diaceutics Plc LSE:DXRX London Ordinary Share GB00BJQTGV64 ORD GBP0.002
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.00p +0.00% 89.50p 87.00p 92.00p 89.50p 89.50p 89.50p 266 08:00:00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology - - - - 62

Diaceutics PLC Holding(s) in Company

25/03/2019 7:01am

UK Regulatory (RNS & others)


TIDMDXRX

RNS Number : 8053T

Diaceutics PLC

25 March 2019

TR-1: Standard form for notification of major holdings

 
 NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and 
  to the FCA in Microsoft Word format if possible)(i) 
 
 1a. Identity of the issuer or the                                          DIACEUTICS PLC 
  underlying issuer of existing shares 
  to which voting rights are attached(ii) 
  : 
                                                             -------------------------------------------- 
 1b. Please indicate if the issuer is a non-UK issuer (please mark with 
  an "X" if appropriate) 
 Non-UK issuer 
                                                                                                     ---- 
 2. Reason for the notification (please mark the appropriate box or boxes 
  with an "X") 
 An acquisition or disposal of voting rights                                                           X 
                                                                                                     ---- 
 An acquisition or disposal of financial instruments 
                                                                                                     ---- 
 An event changing the breakdown of voting rights                                                      X 
                                                                                                     ---- 
 Other (please specify)(iii) : 
                                                                                                     ---- 
 3. Details of person subject to the notification obligation(iv) 
 Name                                                         CANACCORD GENUITY GROUP INC 
 City and country of registered office                        VANCOUVER, CANADA 
  (if applicable) 
 4. Full name of shareholder(s) (if different from 3.)(v) 
 Name                                                         DISCRETIONARY CLIENTS 
                                                             -------------------------------------------- 
 City and country of registered office                        As above 
  (if applicable) 
                                                             -------------------------------------------- 
 5. Date on which the threshold was                           21 MARCH 2019 
  crossed or reached(vi) : 
                                                             -------------------------------------------- 
 6. Date on which issuer notified (DD/MM/YYYY):               22 MARCH 2019 
                                                             -------------------------------------------- 
 7. Total positions of person(s) subject to the notification obligation 
                              % of voting       % of voting rights    Total of both   Total number 
                            rights attached      through financial     in % (8.A +     of voting rights 
                            to shares (total        instruments            8.B)        of issuer(vii) 
                                of 8. A)           (total of 8.B 
                                                    1 + 8.B 2) 
                          ------------------  ---------------------  --------------  -------------------- 
 Resulting situation 
  on the date 
  on which threshold 
  was crossed 
  or reached               9.8285                                     9.8285          69,583,077 
                          ------------------  ---------------------  --------------  -------------------- 
 Position of               N/A                                        N/A 
  previous notification 
  (if 
  applicable) 
                          ------------------  ---------------------  --------------  -------------------- 
 
 
 
 8. Notified details of the resulting situation on the date on which the 
  threshold was crossed or reached(viii) 
 A: Voting rights attached to shares 
 Class/type of     Number of voting rights(ix)                     % of voting rights 
  shares 
  ISIN code (if 
  possible) 
                          Direct                 Indirect                  Direct                 Indirect 
                    (Art 9 of Directive     (Art 10 of Directive     (Art 9 of Directive     (Art 10 of Directive 
                        2004/109/EC)            2004/109/EC)        2004/109/EC) (DTR5.1)        2004/109/EC) 
                          (DTR5.1)               (DTR5.2.1)                                       (DTR5.2.1) 
                                          ---------------------- 
 GB00BJQTGV64                              6,839,000                                        9.8285 
                                          ----------------------  -----------------------  ---------------------- 
 
 
 
 
 SUBTOTAL 8. A                                6,839,000                                      9.8285 
 
 B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC 
  (DTR5.3.1.1 (a)) 
 Type of financial         Expiration   Exercise/                      Number of voting            % of voting 
  instrument                date(x)      Conversion Period(xi)          rights that may             rights 
                                                                        be acquired if 
                                                                        the instrument 
                                                                        is 
                                                                        exercised/converted. 
                          -----------  -----------------------------  --------------------------  ----------------- 
 
 
 
                                        SUBTOTAL 8. B 1 
                                       -----------------------------  --------------------------  ----------------- 
 
 B 2: Financial Instruments with similar economic effect according to 
  Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b)) 
 Type of financial    Expiration        Exercise/          Physical or            Number of        % of voting 
  instrument           date(x)           Conversion         cash                   voting rights    rights 
                                         Period (xi)        settlement(xii) 
                     ----------------  -----------------  ---------------------  --------------- 
 
 
 
                                                           SUBTOTAL 8.B.2 
                                                          ---------------------  --------------- 
 
 
 
 
 9. Information in relation to the person subject to the notification 
  obligation (please mark the 
  applicable box with an "X") 
 Person subject to the notification obligation is not controlled 
  by any natural person or legal entity and does not control any other 
  undertaking(s) holding directly or indirectly an interest in the 
  (underlying) issuer(xiii) 
 Full chain of controlled undertakings through which the voting rights                         X 
  and/or the 
  financial instruments are effectively held starting with the ultimate 
  controlling natural person or legal entity(xiv) (please add additional 
  rows as necessary) 
        Name(xv)            % of voting rights      % of voting rights       Total of both if 
                              if it equals or        through financial        it equals or is 
                             is higher than the      instruments if it        higher than the 
                            notifiable threshold    equals or is higher     notifiable threshold 
                                                    than the notifiable 
                                                         threshold 
                          ----------------------  ---------------------  ------------------------ 
 Canaccord Genuity 
  Group Inc.               9.8285                                         9.8285 
                          ----------------------  ---------------------  ------------------------ 
 Canaccord Genuity 
  Wealth Group Holdings 
  Limited                  9.8285                                         9.8285 
                          ----------------------  ---------------------  ------------------------ 
 Canaccord Genuity 
  Wealth Group Holdings 
  (Jersey) Limited         9.8285                                         9.8285 
                          ----------------------  ---------------------  ------------------------ 
 Hargreave Hale Ltd        9.8285                                         9.8285 
                          ----------------------  ---------------------  ------------------------ 
 
 10. In case of proxy voting, please identify: 
 Name of the proxy holder 
                                                  ----------------------------------------------- 
 The number and % of voting rights 
  held 
                                                  ----------------------------------------------- 
 The date until which the voting rights 
  will be held 
                                                  ----------------------------------------------- 
 
 11. Additional information(xvi) 
 The change in the percentage of shares held is mainly due to participation 
  in the placing by Diaceutics plc, the shares from which were admitted 
  to AIM on 21/03/2019. 
 
 
 
 Place of completion   BLACKPOOL, ENGLAND 
 Date of completion    22 MARCH 2019 
                      ------------------- 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

HOLVZLFLKXFZBBK

(END) Dow Jones Newswires

March 25, 2019 03:01 ET (07:01 GMT)

1 Year Diaceutics Chart

1 Year Diaceutics Chart

1 Month Diaceutics Chart

1 Month Diaceutics Chart
Your Recent History
LSE
DXRX
Diaceutics
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20190718 09:22:48